Research ArticleProstate Cancer

Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer

See allHide authors and affiliations

Science Translational Medicine  06 Feb 2019:
Vol. 11, Issue 478, eaau5758
DOI: 10.1126/scitranslmed.aau5758

Article Information

vol. 11 no. 478

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication June 25, 2018
  • Resubmitted September 17, 2018
  • Accepted for publication January 15, 2019

Author Information

  1. Matthew J. Watt1,2,*,
  2. Ashlee K. Clark3,4,
  3. Luke A. Selth5,
  4. Vanessa R. Haynes1,2,
  5. Natalie Lister3,4,
  6. Richard Rebello3,4,6,
  7. Laura H. Porter3,4,
  8. Birunthi Niranjan3,4,
  9. Sarah T. Whitby2,3,
  10. Jennifer Lo2,
  11. Cheng Huang7,
  12. Ralf B. Schittenhelm7,
  13. Kimberley E. Anderson8,
  14. Luc Furic3,4,9,10,
  15. Poornima R. Wijayaratne2,
  16. Maria Matzaris2,
  17. Magdalene K. Montgomery1,2,
  18. Melissa Papargiris3,4,
  19. Sam Norden11,
  20. Maria Febbraio12,
  21. Gail P. Risbridger3,4,9,10,
  22. Mark Frydenberg13,
  23. Daniel K. Nomura8 and
  24. Renea A. Taylor3,4,9,*
  1. 1Department of Physiology, University of Melbourne, Melbourne, VIC 3010, Australia.
  2. 2Monash Biomedicine Discovery Institute, Metabolic Disease and Obesity, Department of Physiology, Monash University, Clayton, VIC 3800, Australia.
  3. 3Monash Partners Comprehensive Cancer Consortium, Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Physiology, Monash University, Clayton, VIC 3800, Australia.
  4. 4Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC 3800, Australia.
  5. 5Dame Roma Mitchell Cancer Research Laboratories and Freemasons Foundation Centre for Men’s Health, Adelaide Medical School, University of Adelaide, Adelaide, SA 5005, Australia.
  6. 6Cancer Research UK Manchester Institute, University of Manchester, Manchester M20 4GJ, UK.
  7. 7Monash Biomedical Proteomics Facility and Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia.
  8. 8Departments of Chemistry, Molecular and Cell Biology, and Nutritional Sciences and Toxicology, University of California, Berkley, Berkeley, CA, USA.
  9. 9Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
  10. 10Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia.
  11. 11TissuPath, Mount Waverley, VIC 3149, Australia.
  12. 12Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta T6G 2R7, Canada.
  13. 13Department of Surgery, Faculty of Medicine, Monash University, Clayton, VIC 3800, Australia.
  1. *Corresponding author. Email: matt.watt{at}unimelb.edu.au (M.J.W.); renea.taylor{at}monash.edu (R.A.T.)

Altmetric

Article usage

Article usage: February 2019 to April 2019

AbstractFullPdf
Feb 201968091433654
Mar 20191505203193
Apr 2019890143125